| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Ducentis BioTherapeutics
Ducentis is a pre-clinical stage company that aims to develop novel therapies fo…
|
2022-09-07 | Acquisition | Complete | $400.0M | Deal → |